Apimeds Pharmaceuticals US, Inc. (APUS NYSE MKT) stock market data APIs
$1.8913
0(0%)
as of September 16, 2025
Try our APIs with
free plan!
Apimeds Pharmaceuticals US, Inc. Financial Data Overview
Price chart is built with
Anychart
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company has a strategic alliance with University of Alabama for the development of ai² future labs program. The company was incorporated in 2020 and is based in Matawan, New Jersey.
Prev. Close
1.8913
Open
1.8913
High
1.9401
Low
1.7657
52 wk Range
1.37-4
Market Cap
24 310 K
Shares Outstanding
11 576 K
EPS
-0.2117
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Apimeds Pharmaceuticals US, Inc. data using free add-ons & libraries
Get Apimeds Pharmaceuticals US, Inc. Fundamental Data
Apimeds Pharmaceuticals US, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Apimeds Pharmaceuticals US, Inc. News
New
Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHAN...
Apimeds Pharmaceuticals adds two key executives to leadership team
NEW YORK - Apimeds Pharmaceuticals US, Inc. (NYSE American:APUS), a clinical-stage biopharmaceutical company with a market capitalization of $21.3 million, has appointed two new executives to its lead...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
